Israel Englander Rocket Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,202,495 shares of RCKT stock, worth $14.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,202,495

Previous 105,325 1041.7%

Holding current value

$14.5 Million

Previous $2.27 Million 879.71%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.6 - $25.88 $19.3 Million - $28.4 Million	1,097,170 Added 1041.7%	1,202,495 $22.2 Million
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $2.18 Million - $2.81 Million	105,325 New	105,325 $2.27 Million
Q4 2023 Feb 14, 2024	SELL	$16.78 - $31.94 $2.09 Million - $3.97 Million	-124,351 Reduced 69.39%	54,865 $1.64 Million
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $2.97 Million - $4.23 Million	179,216 New	179,216 $3.56 Million
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $1.52 Million - $2.26 Million	122,976 Added 125.99%	220,586 $3.52 Million
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $593,378 - $1.24 Million	74,545 Added 323.2%	97,610 $1.34 Million
Q1 2022 May 16, 2022	SELL	$13.16 - $23.68 $2.6 Million - $4.69 Million	-197,948 Reduced 89.56%	23,065 $366,000
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $4.76 Million - $7.96 Million	221,013 New	221,013 $4.83 Million
Q2 2021 Aug 16, 2021	SELL	$39.41 - $47.25 $4.91 Million - $5.89 Million	-124,560 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $4.84 Million - $7.36 Million	-111,658 Reduced 47.27%	124,560 $5.53 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $4.52 Million - $11.6 Million	194,126 Added 461.19%	236,218 $13 Million
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $3.34 Million - $4.66 Million	-162,904 Reduced 79.47%	42,092 $962,000
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $2.73 Million - $4.63 Million	204,996 New	204,996 $4.29 Million
Q1 2020 May 14, 2020	SELL	$9.71 - $25.11 $938,976 - $2.43 Million	-96,702 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $535,112 - $1.17 Million	48,339 Added 99.95%	96,702 $2.2 Million
Q3 2019 Nov 14, 2019	SELL	$10.85 - $14.78 $5.78 Million - $7.87 Million	-532,761 Reduced 91.68%	48,363 $563,000
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.81 $1.87 Million - $2.47 Million	124,538 Added 27.28%	581,124 $8.72 Million
Q1 2019 May 14, 2019	BUY	$13.45 - $19.01 $5.31 Million - $7.51 Million	395,124 Added 642.88%	456,586 $8.01 Million
Q4 2018 Feb 14, 2019	SELL	$11.21 - $23.53 $897,259 - $1.88 Million	-80,041 Reduced 56.56%	61,462 $911,000
Q3 2018 Nov 14, 2018	BUY	$18.5 - $25.49 $894,308 - $1.23 Million	48,341 Added 51.89%	141,503 $3.48 Million
Q2 2018 Aug 14, 2018	BUY	$14.58 - $23.0 $549,024 - $866,088	37,656 Added 67.84%	93,162 $1.83 Million
Q1 2018 May 15, 2018	BUY	$11.68 - $19.19 $648,310 - $1.07 Million	55,506 New	55,506 $1.04 Million

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $910M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account